DIABETES

July 21, 2021

Dulaglutide Might Reduce Erectile Dysfunction in T2D Patients

July 7, 2021

Here Are the Best Medications for Controlling Blood Sugar in T2D

June 16, 2021

Diverted Nonprescription Insulin Can Be Dangerous for Patients

June 9, 2021

CGM Improves Glucose Levels, Reduces Hypoglycemia in T2D Patients

May 14, 2021

Afinion HbA1c Dx Test

April 28, 2021

Once-Weekly Insulin Shown Safe, Effective in Recent Clinical Trials

March 31, 2021

No Evidence That GLP-1 RAs Increase Breast Cancer Risk in Users

March 10, 2021

Higher-Dose Semaglutide Shown Effective in Aiding T2D Weight Loss

February 24, 2021

COVID-19 and Metformin: What Diabetes Patients Need to Know

February 3, 2021

Metformin Appears Protective Against Some, But Not All, Breast Cancer Types

January 27, 2021

Poor Glycemic Control Raises Risk of Infections in Diabetes Patients

January 20, 2021

Endocrine Society Makes Big Push to Lower Fast-Rising Insulin Prices

January 6, 2021

Should COVID-19 Patients Discontinue Use of SGLT2 Inhibitors for Diabetes?

July 2021

July 2021

In This Issue Digital Magazine Archives Subscription

Related CE

$6.97 Per CE Exam or $59 for 12 Lessons

Oral Semaglutide: A New GLP-1 Receptor Agonist Product for the Treatment of Type 2 Diabetes

View More CE

Copyright © 2000 - 2021 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.